Caption Management, LLC Innoviva, Inc. Transaction History

Caption Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$13.06 - $17.24 $415,033 - $547,869	-31,779 Reduced 41.81%	44,221 $739,000
Q2 2021 Aug 16, 2021	BUY	$11.45 - $13.96 $870,200 - $1.06 Million	76,000 New	76,000 $1.02 Million
Q1 2021 May 17, 2021	SELL	$11.06 - $12.87 $199,080 - $231,660	-18,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$9.33 - $12.48 $167,940 - $224,640	18,000 New	18,000 $222,000
Q3 2020 Nov 16, 2020	SELL	$10.33 - $14.49 $3.34 Million - $4.68 Million	-323,155 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$11.49 - $15.26 $78,649 - $104,454	-6,845 Reduced 2.07%	323,155 $4.52 Million
Q1 2020 May 15, 2020	BUY	$8.11 - $15.23 $1.77 Million - $3.32 Million	217,899 Added 194.38%	330,000 $3.88 Million
Q4 2019 Feb 13, 2020	SELL	$10.28 - $14.38 $1.34 Million - $1.87 Million	-129,899 Reduced 53.68%	112,101 $1.59 Million
Q3 2019 Nov 14, 2019	BUY	$10.05 - $14.55 $2.43 Million - $3.52 Million	242,000 New	242,000 $2.55 Million

227

78.9M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.24B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.